Cargando…
Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
Oxaliplatin is an essential drug in the chemotherapy of colorectal, gastric, and pancreatic cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far, animal models of oxaliplatin-induced peripheral neuropathy have been established. The mechanisms of development of ne...
Autores principales: | Kawashiri, Takehiro, Mine, Keisuke, Kobayashi, Daisuke, Inoue, Mizuki, Ushio, Soichiro, Uchida, Mayako, Egashira, Nobuaki, Shimazoe, Takao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866815/ https://www.ncbi.nlm.nih.gov/pubmed/33573316 http://dx.doi.org/10.3390/ijms22031393 |
Ejemplares similares
-
Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
por: Kawashiri, Takehiro, et al.
Publicado: (2021) -
Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro
por: Shigematsu, Nao, et al.
Publicado: (2020) -
Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
por: Mine, Keisuke, et al.
Publicado: (2022) -
Inhibitory Effect of α1 Receptor Antagonists on Paclitaxel-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
por: Mori, Kohei, et al.
Publicado: (2022) -
Oral administration of Cystine and Theanine ameliorates oxaliplatin-induced chronic peripheral neuropathy in rodents
por: Kawashiri, Takehiro, et al.
Publicado: (2020)